Forum Update: Supporting Community-Led Discussion
The forum was created as a space for shared learning and peer support, and as the community grows, we want to lean more fully into that purpose.
Going forward, PAAB will be taking a more listening-first role in forum discussions. Rather than responding immediately to every question, we’ll be encouraging members to engage with one another, share experiences, and help build collective understanding. PAAB will continue to monitor conversations and will step in to:
- Correct any misunderstandings
- Provide guidance when questions remain unanswered after a few days
- Support discussions where official clarification is needed
Our goal is to foster a collaborative, trusted community where knowledge is shared and strengthened by everyone’s contributions.
Thank you for being part of the conversation.
Website Naming
-
We have a situation where our brand has 2 indications in 2 different therapeutic areas. We wanted to run with brand.ca but realize that if a patient prescribed the brand for TA #1 is directed to the site, we can't mention the indications for TA #2 as that would link brand to indication for an indication that the patient was not prescribed. We were informed that this is the case when we tried to create an enrolment form that listed indications from 2 different TAs. I was wondering if PAAB has reviewed other brand sites with this situation and how it could be addressed in the URL.
-
We have a situation where our brand has 2 indications in 2 different therapeutic areas. We wanted to run with brand.ca but realize that if a patient prescribed the brand for TA #1 is directed to the site, we can't mention the indications for TA #2 as that would link brand to indication for an indication that the patient was not prescribed. We were informed that this is the case when we tried to create an enrolment form that listed indications from 2 different TAs. I was wondering if PAAB has reviewed other brand sites with this situation and how it could be addressed in the URL.
Hi @gmc
We have reviewed such sites. In general, the URL for the website (brand.ca) is to the homepage where gating can be started with the DIN number for the patient to enter. Once the patient is in the site, part 3 of the Product Monograph will dictate whether patients can see other therapeutic areas/ indications, i.e. is there only one part 3 for all indications or separate part 3s for separate indications? (we refer you to Section 1.1b of the Guidance on Branded Patient Information). If they are separate part 3's, then one suggestion is for the site to offer an option for the patient to enter their indication in order to enter the appropriate section.
